sorafenib has been researched along with concanavalin a in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 17,959 | 82 | 1,337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armeli Iapichino, EC; Bramanti, A; Bramanti, P; Ciurleo, R; Fagone, P; Magro, GG; Mangano, K; Nicoletti, F; Pesce, A; Petralia, MC | 1 |
| Ai, Y; Cao, Y; Ma, Y; Sun, Q; Wang, J; Wang, X; Yan, B; Zhang, Z | 1 |
2 other study(ies) available for sorafenib and concanavalin a
| Article | Year |
|---|---|
Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis.
Topics: Angiogenesis Inhibitors; Animals; Computer Simulation; Concanavalin A; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Hepatic Stellate Cells; Humans; Imatinib Mesylate; Liver; Liver Cirrhosis; Mice; Mice, Inbred BALB C; Protein Kinase Inhibitors; Receptors, Platelet-Derived Growth Factor; Sorafenib | 2020 |
Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1.
Topics: Animals; Cell Line, Tumor; Cell Membrane; Concanavalin A; Cytochrome P-450 Enzyme System; Cytochrome-B(5) Reductase; Electron Transport; Fatty Acids, Unsaturated; Ferroptosis; HEK293 Cells; HeLa Cells; Humans; Hydrogen Peroxide; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; NADP; Oxygen; Phenylurea Compounds; Piperazines; Pyridines; Sorafenib | 2021 |